BioSpecifics appoints board members
This article was originally published in Scrip
Executive Summary
Lynbrook, New York-based BioSpecifics Technologies, a biopharmaceutical company developing first-in-class collagenase-based products, has named two new members to its board of directors: Jennifer Chao and Dr Jyrki Mattila. Ms Chao is an advisory analyst at CoreStrategies Management, a strategic consulting firm she founded in 2008 focused on providing transformational strategy and maximizing corporate valuation. Meanwhile, Dr Mattila is chief business officer of iCeutica. Prior to joining iCeutica in 2013, Dr Mattila was president and CEO of LZ Therapeutics.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.